vTv Therapeutics (VTVT) Other Non-Current Liabilities (2014 - 2022)

vTv Therapeutics has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $770000.0 for Q1 2022.

• In Q1 2022, Other Non-Current Liabilities rose 1440.0% year-over-year to $770000.0; the TTM figure through Mar 2022 stood at $770000.0 (up 1440.0% YoY), while the FY2021 annual figure was $1.3 million, up 2424.0% from the prior year.
• Other Non-Current Liabilities came in at $770000.0 for Q1 2022 at vTv Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 million in Q4 2021 to a low of $50000.0 in Q4 2020.
• Average Other Non-Current Liabilities over 5 years is $276294.1, with a median of $258000.0 recorded in 2018.
• Year-over-year, Other Non-Current Liabilities sank 80.77% in 2020 and surged 2424.0% in 2021.
• Over 5 years, Other Non-Current Liabilities stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then slumped by 80.77% to $50000.0 in 2020, then surged by 2424.0% to $1.3 million in 2021, then sank by 38.99% to $770000.0 in 2022.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $770000.0 in Q1 2022, $1.3 million in Q4 2021, and $50000.0 in Q3 2021.